Therapeutic potential of melatonin and melatonergic drugs on K18‐ hACE2 mice infected with SARS‐CoV‐2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of melatonin and melatonergic drugs on K18‐
hACE2
mice infected with SARS‐CoV‐2
Authors
Keywords
-
Journal
JOURNAL OF PINEAL RESEARCH
Volume 72, Issue 1, Pages -
Publisher
Wiley
Online
2021-09-30
DOI
10.1111/jpi.12772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19
- (2021) Victor M. Arce et al. Cellular & Molecular Immunology
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19
- (2021) Claude Kwe Yinda et al. PLoS Pathogens
- Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials
- (2021) Joshua H. Cho et al. BRAIN BEHAVIOR AND IMMUNITY
- Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
- (2021) Cecile King et al. TRENDS IN IMMUNOLOGY
- Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
- (2021) Abdolkarim Hosseini et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
- (2021) Jack P.K. Bravo et al. MOLECULAR CELL
- The interferon landscape along the respiratory tract impacts the severity of COVID-19
- (2021) Benedetta Sposito et al. CELL
- Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations
- (2021) Xiaofeng Zhai et al. JOURNAL OF PINEAL RESEARCH
- Animal models for SARS-CoV-2
- (2021) Chung-Young Lee et al. Current Opinion in Virology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
- (2020) Ren-Di Jiang et al. CELL
- Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
- (2020) Zhuo Zhou et al. Cell Host & Microbe
- A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
- (2020) Shi-Hui Sun et al. Cell Host & Microbe
- Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral‐induced fulminant hepatic failure
- (2020) Irene Crespo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection
- (2020) Gregory Brett Moreau et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
- (2020) Ahmed O. Hassan et al. CELL
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical trial to test the efficacy of melatonin in COVID‐19
- (2020) Dario Acuña‐Castroviejo et al. JOURNAL OF PINEAL RESEARCH
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Structure-Based Virtual Screening Accelerates GPCR Drug Discovery
- (2020) Lei Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
- (2020) Raveen Rathnasinghe et al. Emerging Microbes & Infections
- Melatonin controversies, an update
- (2020) Jean A. Boutin et al. JOURNAL OF PINEAL RESEARCH
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
- (2020) Fatai S. Oladunni et al. Nature Communications
- Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks
- (2019) Rüdiger Hardeland INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin possesses an anti-influenza potential through its immune modulatory effect
- (2019) Shing-Hwa Huang et al. Journal of Functional Foods
- Melatonin Target Proteins: Too Many or Not Enough?
- (2019) Lei Liu et al. Frontiers in Endocrinology
- New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
- (2018) Nava Zisapel BRITISH JOURNAL OF PHARMACOLOGY
- Type I Interferon in Chronic Virus Infection and Cancer
- (2017) Laura M. Snell et al. TRENDS IN IMMUNOLOGY
- MT1and MT2Melatonin Receptors: A Therapeutic Perspective
- (2016) Jiabei Liu et al. Annual Review of Pharmacology and Toxicology
- Update on melatonin receptors: IUPHAR Review 20
- (2016) Ralf Jockers et al. BRITISH JOURNAL OF PHARMACOLOGY
- Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin
- (2016) Irene Crespo et al. JOURNAL OF PINEAL RESEARCH
- Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia-reperfusion injury in rats through suppression of mitochondrial permeability transition
- (2016) Hong-Hwa Chen et al. JOURNAL OF PINEAL RESEARCH
- Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome
- (2016) Yong Zhang et al. JOURNAL OF PINEAL RESEARCH
- SARS-like WIV1-CoV poised for human emergence
- (2016) Vineet D. Menachery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice
- (2015) José A. García et al. FASEB JOURNAL
- Melatonin prevents lung injury induced by hepatic ischemia–reperfusion through anti-inflammatory and anti-apoptosis effects
- (2015) Li Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat
- (2014) Cheuk Kwan Sun et al. JOURNAL OF PINEAL RESEARCH
- Melatonin and its analogs in insomnia and depression
- (2011) Daniel P. Cardinali et al. JOURNAL OF PINEAL RESEARCH
- A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance
- (2010) Susan L. McElroy et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
- (2010) Mark J. Millan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice
- (2010) Sheng-Hai Huang et al. JOURNAL OF PINEAL RESEARCH
- Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
- (2010) Christian de Bodinat et al. NATURE REVIEWS DRUG DISCOVERY
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
- (2010) M. L. Dubocovich et al. PHARMACOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started